USDA, FDA and CDC Share Update on HPAI Detections in Dairy Cattle

Editor's Note: An original version of this release listed Ohio among the states with presumptive positives, which was in error. This release has also been updated to include a link to a frequently asked questions document. 

Press Release

WASHINGTON, March 29, 2024 – The U.S. Department of Agriculture (USDA), Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC), as well as state veterinary and public health officials, are continuing to investigate an illness among dairy cows that is causing decreased lactation, low appetite, and other symptoms.

On Monday, March 25, the agencies confirmed the detection of highly pathogenic avian influenza (HPAI) in two dairy herds in Texas and two dairy herds in Kansas that had cattle exhibiting these symptoms.   

USDA’s National Veterinary Services Laboratories (NVSL) has now also confirmed the presence of HPAI in a Michigan dairy herd that had recently received cows from Texas. Presumptive positive test results have also been received for additional herds in New Mexico, Idaho, and Texas; USDA will share updates if those tests are confirmed positive by NVSL. Federal and state agencies continue to conduct additional testing in swabs from sick animals and in unpasteurized clinical milk samples from sick animals, as well as viral genome sequencing, to assess whether HPAI or another unrelated illness may be underlying any symptoms

The NVSL has also confirmed that the strain of the virus found in Michigan is very similar to the strain confirmed in Texas and Kansas that appears to have been introduced by wild birds (H5N1, Eurasian lineage goose/Guangdong clade 2.3.4.4b).  Initial testing has not found changes to the virus that would make it more transmissible to humans. While cases among humans in direct contact with infected animals are possible, this indicates that the current risk to the public remains low.

Spread of symptoms among the Michigan herd also indicates that HPAI transmission between cattle cannot be ruled out; USDA and partners continue to monitor this closely and have advised veterinarians and producers to practice good biosecurity, test animals before necessary movements, minimize animal movements, and isolate sick cattle from the herd. Among the dairies whose herds are exhibiting symptoms, the affected animals have recovered after isolation with little to no associated mortality reported. 

There continues to be no concern about the safety of the commercial milk supply because products are pasteurized before entering the market, or that this circumstance poses a risk to consumer health. Dairies are required to send only milk from healthy animals into processing for human consumption; milk from impacted animals is being diverted or destroyed so that it does not enter the human food supply. In addition, pasteurization has continually proven to inactivate bacteria and viruses, like influenza, in milk. Pasteurization is required for any milk entering interstate commerce for human consumption. FDA’s longstanding position is that unpasteurized, raw milk can harbor dangerous microorganisms that can pose serious health risks to consumers, and FDA is reminding consumers of the risks associated with raw milk consumption in light of the HPAI detections.

Because of the limited information available about the transmission of HPAI in raw milk, the FDA recommends that industry does not manufacture or sell raw milk or raw/unpasteurized milk cheese products made with milk from cows showing symptoms of illness, including those infected with avian influenza or exposed to those infected with avian influenza.  At this time, the FDA is not aware that any milk or food product from symptomatic cows is entering interstate commerce.  Furthermore, if milk from cows showing symptoms of illness, including those infected with avian influenza or exposed to those infected with avian influenza is intended to be used to feed calves, FDA strongly encourages that it be heat treated to kill harmful bacteria or viruses, such as influenza, before calf feeding. Food safety information from FDA, including information about the sale and consumption of raw milk, can be found here. 

Milk loss resulting from symptomatic cattle to date is too limited to have a major impact on supply and there should be no impact on the price of milk or other dairy products. Further, the U.S. typically has a more than sufficient milk supply in the spring months due to seasonally higher production.

Federal agencies are also working with state and industry partners to encourage farmers and veterinarians to report cattle illnesses quickly so that we can monitor potential additional cases and minimize the impact and risk to farmers, farmworkers, consumers and other animals. Producers are urged to work with their veterinarian to report cattle illnesses quickly and practice enhanced biosecurity measures. More information on biosecurity measures can be found here. 

USDA and federal and state partners will continue to share additional updates as information becomes available. APHIS has also prepared Frequently Asked Questions document, which can be accessed here (420.81 KB).